Banerjee S. Multimorbidity—older adults need health care that can count past one. The Lancet. 2015;385(9968):587-589.
Arokiasamy P, Uttamacharya U, Jain K, Biritwum R, Yawson A, Wu F et al. The impact of multimorbidity on adult physical and mental health in low- and middle-income countries: what does the study on global ageing and adult health (SAGE) reveal?. BMC Medicine. 2015;13(1).
Burns A, Younger J, Morris J, Baldwin R, Tarrier N, Pendleton N et al. Outcomes Following Hip Fracture Surgery: A 2-Year Prospective Study. The American Journal of Geriatric Psychiatry. 2014;22(8):838-844.
Banerjee S, Hellier J, Romeo R, Dewey M, Knapp M, Ballard C et al. Study of the use of antidepressants for depression in dementia: the HTA-SADD trial – a multicentre, randomised, double-blind, placebo-controlled trial of the clinical effectiveness and cost-effectiveness of sertraline and mirtazapine. Health Technol Assess. 2013;17(07).
Mulhern B, Rowen D, Brazier J, Smith S, Romeo R, Tait R et al. Development of DEMQOL-U and DEMQOL-PROXY-U: generation of preference-based indices from DEMQOL and DEMQOL-PROXY for use in economic evaluation. Health Technol Assess. 2013;17(05).
Poppe M, Burleigh S, Banerjee S. Qualitative Evaluation of Advanced Care Planning in Early Dementia (ACP-ED). PLoS ONE. 2013;8(4):e60412.
Barnes T, Banerjee S, Collins N, Treloar A, McIntyre S, Paton C. Antipsychotics in dementia: prevalence and quality of antipsychotic drug prescribing in UK mental health services. The British Journal of Psychiatry. 2012;201(3):221-226.
Romeo R, Knapp M, Hellier J, Dewey M, Ballard C, Baldwin R et al. Cost-effectiveness analyses for mirtazapine and sertraline in dementia: randomised controlled trial. The British Journal of Psychiatry. 2012;202(2):121-128.